Mirae Asset Global ETFs Holdings’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$531K Buy
9,600
+116
+1% +$5.52K ﹤0.01% 1862
2025
Q4
$354K Buy
9,484
+68
+0.7% +$2.76K ﹤0.01% 2070
2025
Q3
$381K Sell
9,416
-1,786
-16% -$59K ﹤0.01% 2000
2025
Q2
$286K Sell
11,202
-962
-8% -$21K ﹤0.01% 2091
2025
Q1
$260K Buy
12,164
+546
+5% +$12.2K ﹤0.01% 2185
2024
Q4
$244K Buy
11,618
+359
+3% +$8.31K ﹤0.01% 2283
2024
Q3
$254K Buy
11,259
+1,497
+15% +$28.9K ﹤0.01% 2256
2024
Q2
$164K Buy
+9,762
New +$157K ﹤0.01% 2357

Other funds holding PAHC

Mirae Asset Global ETFs Holdings's PAHC Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Phibro Animal Health (PAHC) stake by 1.2% in Q1 2026, buying an estimated $5.52K and bringing the position to 9,600 shares worth $531K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Mirae Asset Global ETFs Holdings first reported a position in PAHC in Q2 2024 and has held it in 8 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 9,600 shares of Phibro Animal Health worth $531K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 116 Phibro Animal Health shares in Q1 2026, an estimated $5.52K.
  • Phibro Animal Health made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1862 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Phibro Animal Health in Q2 2024 and has held it in 8 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.